Lerdelimumab

Tax included
Lerdelimumab (CAT-152) is an IgG4 human anti-TGF-β2 recombinant monoclonal antibody. Lerdelimumab can be used as an anti-scarring agent for glaucoma research.
MedChemExpress 
HY-P99695

Data sheet

Size
Multiple sizes
Reactivity
TGF-beta/Smad
CAS
285985-06-0